Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CBT-NPC by CHA Biotech for Parkinson's Disease: Likelihood of Approval
CBT-NPC is under clinical development by CHA Biotech and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...